Skip to main content
Clinical Trials/NCT06202144
NCT06202144
Completed
Not Applicable

Physiological Effects of Personalized Noninvasive Support in Acute Hypoxemic Respiratory Failure

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country20 target enrollmentJanuary 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Hypoxic Respiratory Failure
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
20
Locations
1
Primary Endpoint
Tidal volume
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The optimal noninvasive respiratory support for acute hypoxemic respiratory failure is debated. Recent preliminary data indicate that both pressure-support noninvasive ventilation (NIV) and continuous-positive airway pressure (CPAP) may be of benefit. While often applied interchangeably in clinical practice, NIV and CPAP have different effects on the inspiratory effort, which is the major determinant of self-inflicted lung injury. Also, inspiratory effort widely varies among individuals.

The purpose of this study is to assess the physiological effects of a noninvasive respiratory support approach guided by inspiratory effort, as compared to CPAP and NIV, in patients with moderate-to-severe acute hypoxemic respiratory failure.

Detailed Description

Patients with acute hypoxemic respiratory failure will undergo a decremental pressure-support trial during helmet noninvasive support. The following pressure-support settings will be applied sequentially, with positive end-expiratory pressure kept constant and equal to 10-12 cmH2O: 20 cmH2O, 16 cmH2O, 12 cmH2O, 8 cmH2O and high-flow-driven CPAP. Inspiratory effort will be monitored during the trial through esophageal manometry. The personalized setting of noninvasive support will be defined as the minimal pressure-support level capable of generating inspiratory effort between 5 and 10 cmH2O. Personalized noninvasive support will be then compared to conventionally-set NIV and CPAP in a randomized cross-over trial.

Registry
clinicaltrials.gov
Start Date
January 12, 2024
End Date
June 15, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Acute hypoxemic respiratory failure and PaO2/FiO2\<200 mmHg
  • PaCO2\<45 mmHg
  • Respiratory failure not caused by exacerbation of chronic pulmonary disease, cardiac failure or fluid overload

Exclusion Criteria

  • Pregnancy
  • Contraindication to helmet support
  • Contraindication to esophageal manometry
  • Contraindication to electrical-impedance tomography monitoring
  • Recent surgery involving the abdomen or the thorax
  • Pneumothorax or documented barotrauma

Outcomes

Primary Outcomes

Tidal volume

Time Frame: 1 hour

Tidal volume size, assessed with electrical impedance tomography

Transpulmonary driving pressure

Time Frame: 1 hour

The positive inspiratory swing in transpulmonary pressure, calculated as airway pressure minus esophageal pressure

Secondary Outcomes

  • Inspiratory effort(1 hour)
  • Work of breathing(1 hour)
  • End-expiratory lung impedance(1 hour)
  • Respiratory rate(1 hour)
  • Blood oxygenation(1 hour)
  • Corrected minute ventilation(1 hour)
  • Tidal volume distribution(1 hour)
  • Pendelluft extent(1 hour)
  • Lung compliance(1 hour)
  • Dyspnea(1 hour)

Study Sites (1)

Loading locations...

Similar Trials